Question 1

Am I eligible for this trial based on my current treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas clinical trial (NCT03715933). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of INBRX-109?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas clinical trial (NCT03715933). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas clinical trial (NCT03715933). Contact the study team or your healthcare provider for specific answers.

Question 4

What will the treatment schedule look like if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas clinical trial (NCT03715933). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any specific tests or procedures I will need to undergo?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas clinical trial (NCT03715933). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas clinical trial (NCT03715933). Contact the study team or your healthcare provider for specific answers.

What this study is about